Where does the FDA stand on PRF?
Why This Matters to Aesthetic Clinics…
Summary Table: FDA and PRF for Aesthetics
(use tablet or computer to see table)
Aspect
FDA Status/Requirement
Impact on Aesthetic Clinics
PRF as a Therapy
Not FDA-approved for most uses (off-label)
Must inform patients; procedures are investigational
PRF Preparation Devices
FDA 510(k)-cleared for specific uses
Must use cleared devices to avoid legal risk
Use in Aethetics
Off-label, allowed under practice of medicine
Must follow best practices, maintain records
Key Takeaway
Aesthetic clinics can use PRF if they employ FDA-cleared devices and adhere to best practices, but must recognize that PRF is not FDA-approved for aesthetic applications. This distinction is crucial for legal compliance, patient safety, and ethical marketing 6,9,1.
Ready to get started with PRF and HA-PRF biofillers in your clinic?
QUESTIONS?
Support@RVTMed.com
RVT Medical makes no guarantees regarding individual patient outcomes and specifically disclaims liability for any improper or unauthorized use of the technologies described. Any trademarks, product names, or brands mentioned are the property of their respective owners and are referenced solely for informational purposes.
By engaging with this article, you acknowledge and agree that RVT Medical and its affiliates are not responsible for clinical decisions, misuse, or misinterpretation of the information provided. For further inquiries about product safety, clinical indications, or distributor access, please contact RVT Medical via our website at RVTmed.com.
- Intended Use: Most FDA-cleared devices for PRF are indicated for use in producing platelet concentrates for mixing with bone graft materials in orthopedic or dental applications. Use of PRF for other indications—including aesthetics—is considered “off-label” 9.
- Product Classification: PRF is classified as an autologous blood product. The FDA’s Center for Biologics Evaluation and Research (CBER) oversees blood-derived products, but PRF, like PRP, is generally exempt from the stricter regulatory pathways required for drugs or biologics, provided it is minimally manipulated and used in a homologous manner 1,6.
- Terminology and Confusion: There is ongoing confusion in the literature and regulatory environment due to inconsistent terminology and classification of PRF and related products 9.
- Compliance and Liability: Clinics must use FDA-cleared devices to prepare PRF to remain compliant. Using non-cleared devices or kits increases legal and regulatory risk if complications arise 6,9.
- Off-Label Use: Since PRF is not FDA-approved for aesthetic procedures, its use in this context is off-label. Practitioners must ensure they are well-informed, use PRF based on scientific rationale, and maintain thorough documentation of its use and outcomes 1,6.
- Patient Communication: Clinics should be transparent with patients that PRF for aesthetics is not FDA-approved, which impacts expectations, informed consent, and insurance coverage 6.
- Evolving Regulation: The regulatory landscape for autologous blood products is evolving. Future FDA guidance could change requirements for PRF in aesthetics, so clinics must stay updated on regulatory developments 1,6.
- Marketing Restrictions: Clinics should avoid marketing PRF procedures as “FDA-approved” for aesthetics, as this is misleading and could attract regulatory scrutiny 4,6.
Submit a contact form.
Privacy Policy: We hate spam and promise to keep your email address safe
Clinical Notice & Legal Disclaimer: The content of this page is for educational and informational purposes only and is not intended to serve as medical advice, diagnosis, or treatment. The information presented draws upon publicly available sources, scientific research, and clinical insights relevant to the technologies and therapies covered. Readers and healthcare providers should always consult with licensed medical professionals and regulatory bodies to confirm that any treatment approaches, product applications, or therapeutic claims comply with local legal requirements and evidence-based clinical standards.